Med Life S.A.

F:O0C Germany Medical Care Facilities
Market Cap
$1.16 Billion
€1.13 Billion EUR
Market Cap Rank
#43760 Global
#7085 in Germany
Share Price
€2.14
Change (1 day)
-1.84%
52-Week Range
€1.97 - €2.87
All Time High
€2.87
Categories
Companies in Germany Medical Care Facilities
About

Med Life S.A., a private healthcare provider, provides healthcare services through its clinics and hospitals in Bucharest, Cluj, Braila, Timisoara, Iasi, Galati, Ploiesti, Constanta, and Targu Mures, Romania. The company offers outpatient units and diagnostic imaging services; consultations with general practitioners and specialists; diagnostic imaging investigations; day hospitalization services… Read more

Med Life S.A. (O0C) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2025: 0.146x

Based on the latest financial reports, Med Life S.A. (O0C) has a cash flow conversion efficiency ratio of 0.146x as of September 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€73.52 Million) by net assets (€502.03 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Med Life S.A. - Cash Flow Conversion Efficiency Trend (2021–2024)

This chart illustrates how Med Life S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Med Life S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Med Life S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
E-Elements Technology Co., Ltd.
TWO:6842
 		-0.035x
Mari Petroleum Company Ltd
KAR:MARI
 		N/A
WeLeader Biomedical Co., Ltd.
TWO:7713
 		N/A
SUN INTL RC-08
F:RY1B
 		N/A
Goldenstone Acquisition Limited Warrants
NASDAQ:GDSTW
 		-0.047x
Cuu Long Pharmaceutical JSC
VN:DCL
 		N/A
Greenyn Biotechnology Co., Ltd
TWO:6846
 		N/A
Matba Rofex SA
BA:MTR
 		0.217x

Annual Cash Flow Conversion Efficiency for Med Life S.A. (2021–2024)

The table below shows the annual cash flow conversion efficiency of Med Life S.A. from 2021 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €507.29 Million €276.31 Million 0.545x +46.68%
2023-12-31 €494.19 Million €183.51 Million 0.371x -3.04%
2022-12-31 €482.04 Million €184.62 Million 0.383x -35.76%
2021-12-31 €381.40 Million €227.40 Million 0.596x --